Has Patricia Lopez received payments from drug or device companies?

Yes. Drug and device makers reported $9,375 in general payments to Patricia Lopez across 56 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Patricia Lopez did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Patricia Lopez come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Patricia Lopez

Family · Orlando, FLNPI 1215409735

Payments from drug & device makers

What this record shows

20 manufacturers reported payments, led by Chiesi USA, Inc. at 26.9% of the total. 2025 is the largest year on record at $5,012, more than ten times the $77 reported in 2021. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,375in general payments, 2019–2025

Across 56 payments — averaging $167.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Chiesi USA, Inc.$3K
Merck$2K
Astrazeneca UK Limited$2K
AstraZeneca$245
Axsome Therapeutics, Inc.$239
Neurocrine Biosciences, Inc.$233
plus $2K from 14 others

$1,513in research payments, 2019–2025

Across 12 payments — averaging $126.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Regeneron$2K

What the payments were for

Travel & lodging$5,26656%
Food & beverage$4,10944%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Chiesi USA, Inc.	2	$2,520
Merck	16	$2,283
Astrazeneca UK Limited	12	$1,718
AstraZeneca	2	$245
Axsome Therapeutics, Inc.	2	$239
Neurocrine Biosciences, Inc.	2	$233
Teva Pharmaceuticals USA, Inc.	2	$231
Paratek Pharmaceuticals, Inc.	2	$226
Novo Nordisk	2	$220
Amgen(2 entities)	2	$218
Sanofi	2	$191
AbbVie	2	$172
Gilead	1	$130
Grifols USA, LLC	1	$125
Vanda Pharmaceuticals Inc.	1	$125
Idorsia Pharmaceuticals US Inc	1	$121
Biogen	1	$107
Novartis	1	$106
Johnson & Johnson	1	$87
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$77

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,375 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Other family in Orlando

Donna OrtizOrlando$417K
Lindsey McCabeOrlando$37K
Lewis HarringtonTampa$954K
Danielle PharesFt Lauderdale$713K
Patrick SzarazMiami$327K
Deena RodneyMaitland$323K
Yamila MelendezMiami$212K
Holly BoydLand O Lakes$200K
Rachael BuschLoxahatchee$189K
Victor Tatis de la NuezMiramar$161K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →